Company intelligence / Profile preview

RareMoon Consulting

Washington, District of Columbia, United Statesraremoonconsulting.com ↗

Ownership: Private
Development stage: Other

Overview

RareMoon Consulting is a leading US-based regulatory consultancy specializing in rare disease and orphan drug development. The firm has supported more than 60 sponsors and worked on over 75 unique assets—including 45 gene therapy programs—by providing strategic and operational guidance for FDA and EMA submissions with a reported 100% success rate[1][2][4].

Therapeutic areas: Rare Diseases
Modalities: Gene therapyAdvanced therapy medicinal products (ATMPs)Small molecule (as part of regulatory support for orphan drugs)Biologic (as part of regulatory support for orphan drugs)
Industry: Consulting

Beyond the preview

Go deeper on RareMoon Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RareMoon Consulting.

Explore the full profile